GH
Guardant Health
GH·NASDAQRedwood City CAFounded 20122,000 employees
Mid CapbiotechPublicOncology
Platform: Guardant360 Liquid
Market Cap
$5B
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (GH)
Loading GH stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GH-3607 | GH-3607 | NDA/BLA | 1 | PSMA | HCC | ||
| GH-9188 | GH-9188 | Phase 1 | 1 | CDK4/6 | NBAML | ||
| Sovafotisoran | GH-964 | Phase 1 | 2 | KIF18A | CFCeliac |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)